Breast Cancer Clinical Trial

Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates

Summary

The primary goal of this study is to determine if preoperative breast MRI findings resulted in more extensive surgery, i.e., mastectomy than breast conserving surgery, i.e., lumpectomy in early stage breast cancers at Summa Akron City Hospital. Early stage breast cancer is defined as breast tumor size less than 5 cm.

The objectives are to:

Review early stage breast cancer patient cases treated at Summa Akron City Hospital between 2006 and 2009 to evaluate clinical and pathological staging
Determine the results of preoperative breast MRI and the impact on type of surgery performed
Evaluate the decision to have mastectomy rather than lumpectomy, i.e., physician or patient decision and if this decision was based on breast MRI findings

View Full Description

Full Description

Early stage breast cancer cases between 2006 and 2009 will be identified by the Summa Akron City Hospital cancer registry. The cases will be reviewed and abstracted. The abstracted data will include results of physical breast examinations, mammograms, sonograms, breast MRI reports, biopsy procedure notes and pathology reports to illustrate the clinical stage. Definitive surgical pathology reports will be included in the abstracted data to demonstrate the final pathologic stage of the breast cancer.

A database will be developed to capture the abstracted data. Outcomes will be determined based on final pathology reports.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

early stage breast cancer between 2006-2009
preoperative MRI

Exclusion Criteria:

-

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT01166581

Recruitment Status:

Terminated

Sponsor:

Summa Health System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Summa Akron City Hospital
Akron Ohio, 44304, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT01166581

Recruitment Status:

Terminated

Sponsor:


Summa Health System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider